SCHEMBL24091884

SCHEMBL24091884

O=C(c1ccccc1)c1ccc2c(c1)Cc1ccc(N3c4ccccc4N(c4ccccc4)c4ccccc43)cc1C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ TSHR P16473 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ STAT1 P42224 1/20 0.43
▸ ACHE P22303 1/20 0.42
▸ BACE1 P56817 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ SRD5A2 P31213 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24091898 0.80 NPC1 (0.43) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL24091887 0.78 NPC1 (0.38) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL11037624 0.75 HPGD (0.58) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL2186803 0.74 SRD5A2 (0.66) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL14235303 0.74 L3MBTL1 (0.57) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL30738988 0.74 SRD5A2 (0.66) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL14235651 0.74 L3MBTL1 (0.57) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL14235652 0.74 L3MBTL1 (0.57) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL14235653 0.74 L3MBTL1 (0.57) NPC1ALDH1A1RAB9ATSHRHPGD
SCHEMBL2188139 0.74 SRD5A2 (0.66) NPC1ALDH1A1RAB9ATSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201291-B2 Organic molecules having two non-conjugated bridges between a donor and an acceptor for effective thermally activated delayed fluorescence for use in optoelectronic devices SICHUAN KNOWLEDGE EXPRESS INSTITUTE FOR INNOVATIVE TECHNOLOGIES CO., LTD (CN) 2021-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11201291-B2 Organic molecules having two non-conjugated bridges between a donor and an acceptor for effective thermally activated delayed fluorescence for use in optoelectronic devices CCND1, CCNT1, CCND2 NPC1 1900/4885ALDH1A1 168/4885RAB9A 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback